Neuroimmunology Branch Repository
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01581567|
Recruitment Status : Completed
First Posted : April 20, 2012
Last Update Posted : March 2, 2018
|First Submitted Date||April 19, 2012|
|First Posted Date||April 20, 2012|
|Last Update Posted Date||March 2, 2018|
|Start Date||July 15, 2011|
|Primary Completion Date||Not Provided|
|Current Primary Outcome Measures
||Data samples will be analyzed as approved under original protocol and as amended with IRB approval. Data and samples that were obtained with consent for this study or with approval for future use may be analyzed on site or sent to a repository.|
|Original Primary Outcome Measures||Not Provided|
|Change History||Complete list of historical versions of study NCT01581567 on ClinicalTrials.gov Archive Site|
|Current Secondary Outcome Measures||Not Provided|
|Original Secondary Outcome Measures||Not Provided|
|Current Other Outcome Measures||Not Provided|
|Original Other Outcome Measures||Not Provided|
|Brief Title||Neuroimmunology Branch Repository|
|Official Title||NIB Repository Protocol|
- Information and samples collected from participants in medical research studies can be useful even after the original study is complete. Researchers can use the information and samples to learn more about multiple sclerosis or other immune system disorders. They can also be used for research into other disorders. Researchers would like to get permission to use samples collected from older studies to launch new lines of research.
- To look at information and samples from earlier National Institutes of Health Neuroimmunology Branch studies.
- People who provided samples and medical information for earlier studies.
The purpose of this protocol is to enable prospective IRB review of research using human samples and data collected under other Neuroimmunology Branch (NIB) protocols and to enable retrospective review of samples and data from the branch s protocols that have been terminated prior to full data analysis and publication.
Subjects who previously participated in NIH protocols for whom we have samples or data whose wishes regarding use of their samples/data for research other than that specified in the initial protocol is not known, or where we would like to use their samples or data for purposes other than those they have consented for may be enrolled in this protocol if they are able to be contacted and consent to additional use of their samples or data.
Data and Sample Ascension
Data and samples may include but are not limited to demographic and personal health information, psychological or psychiatric testing, blood, urine, cerebrospinal fluid (CSF) or other body fluids or tissues, results of medical and/or physiological evaluation, and medical imaging.
Data and samples will enter this protocol from the following terminated IRB-approved protocols under which all human subject enrollment and participation is complete including:
|Study Design||Time Perspective: Other|
|Target Follow-Up Duration||Not Provided|
|Sampling Method||Not Provided|
|Study Population||Not Provided|
|Study Groups/Cohorts||Not Provided|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Completion Date||Not Provided|
|Primary Completion Date||Not Provided|
|Ages||Child, Adult, Senior|
|Accepts Healthy Volunteers||No|
|Contacts||Contact information is only displayed when the study is recruiting subjects|
|Listed Location Countries||United States|
|Removed Location Countries|
|Other Study ID Numbers||110210
|Has Data Monitoring Committee||Not Provided|
|U.S. FDA-regulated Product||Not Provided|
|IPD Sharing Statement||Not Provided|
|Responsible Party||National Institutes of Health Clinical Center (CC) ( National Institute of Neurological Disorders and Stroke (NINDS) )|
|Study Sponsor||National Institute of Neurological Disorders and Stroke (NINDS)|
|PRS Account||National Institutes of Health Clinical Center (CC)|
|Verification Date||February 9, 2018|